Insurance, Pharmaceutical Services
"Insurance, Pharmaceutical Services" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.
| Descriptor ID |
D007356
|
| MeSH Number(s) |
N03.219.521.576.343.575
|
| Concept/Terms |
Insurance, Pharmaceutical Services- Insurance, Pharmaceutical Services
- Pharmacy Services Insurance
- Pharmaceutic Services Insurance
- Pharmaceutical Services Insurance
- Insurance, Pharmaceutic Services
- Insurance, Pharmacy Services
Drug Benefit Plans- Drug Benefit Plans
- Drug Benefit Plan
- Plan, Drug Benefit
- Plans, Drug Benefit
|
Below are MeSH descriptors whose meaning is more general than "Insurance, Pharmaceutical Services".
Below are MeSH descriptors whose meaning is more specific than "Insurance, Pharmaceutical Services".
This graph shows the total number of publications written about "Insurance, Pharmaceutical Services" by people in this website by year, and whether "Insurance, Pharmaceutical Services" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insurance, Pharmaceutical Services" by people in Profiles.
-
Variation in US private health plans' coverage of orphan drugs. Am J Manag Care. 2019 10; 25(10):508-512.
-
Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011. J Clin Oncol. 2015 Jul 01; 33(19):2190-6.
-
The impact of the Medicare Part D prescription benefit on generic drug use. J Gen Intern Med. 2008 Oct; 23(10):1673-8.
-
Mental health policy and psychotropic drugs. Milbank Q. 2005; 83(2):271-98.
-
The effect of pharmaceutical benefits managers: is it being evaluated? Ann Intern Med. 1996 May 15; 124(10):906-13.